FGF23 and hypophosphatemia: In a 52-yr-old female with FGF23-mediated hypophosphatemia secondary to TIO due to meningiomas not amenable to surgery, burosumab normalized serum phosphate levels and improved pain at previous multiple fracture sites and mobility, progressing from being wheelchair-bound to using a walker by wk 23.39